The team is made of doctors and scientists whose main mission is to develop and deliver highly sensitive and accurate evidence-based genetic tests. Applying cutting-edge genetic analysis tools and our proprietary algorithms, we search for genetic errors, responsible for human diseases.


Anna Wójcicka, MD, PhD; Prof. Krystian Jażdżewski, MD, PhD


Anna Wójcicka, MD, PhD – a biologist – geneticist, medical doctor and manager of innovation. She believes that genetic diagnostics is one of the most important factors, tailoring the personalized medicine of XXI century. Anna graduated from the Medical University of Warsaw, the University of Warsaw and the Warsaw School of Economics. She was an intern at the Medical Genetics Department of the Vrije Universiteit in Amsterdam, the Molecular Endocrinology Laboratory, Imperial College London and the Comprehensive Cancer Center, Ohio State University, Columbus (USA). She is an author of a range of scientific publications on cancer genetics and a manager of research projects in this field. She was granted a Very Important Polish Innovator title by the Polish Emblem Foundation „Poland Now”, a scholarship of the Minister of Higher Education for outstanding scientist. In 2017, she received the title of Businesswoman of the Year, Woman in New Technologies.

Prof. Krystian Jażdżewski, MD, PhD – medical doctor, endocrinologist, oncogeneticist, currently conducting specialization in clinical genetics. He is devoting all his efforts to make genetic testing available for every Polish citizen. His interests are particularly focused on testing for hereditary cancer, allowing for early prevention and treatment of the disease.  He’s been conducting research on the genetics of human diseases and the use of genomic sequencing in medicine. He worked for 10 years in the USA, in one of the world best cancer inheritance research teams. During that time, Krystian discovered a gene responsible for thyroid cancer inheritance. His publication was reviewed in Faculty 1000 Medicine and ranked among the best 4% of reports. Krystian came back to Poland with the intention to use his experience to promote genetic testing for hereditary cancers.



Research interest:

  • Comprehensive genetic diagnostics of thrombotic microangiopathies
  • Validation of the available serological tests and determination of the level of anti-SARS-CoV-2 IgG antibodies within 1,3,9 and 12 months from the onset of COVID-19
  • Work related to the development, testing and improvement of products and services to combat the COVID-19 pandemic.

Unique research equipment:

  • Hiseq 4000, Ilumina
  • Biomek i5, i7, Beckman Coulter
  • MiniSeq, Ilumina

Research services:

  • Genetic tests
  • genomic analysis using the NGS method